
Archived App (Last seen on 21 Feb 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
Details
About
This app allows physicians and pharmaceutical professionals to easily browse and request custom compound prescriptions from licensed pharmacists. It offers a streamlined process for submitting requests and includes features for patient communication and accessing a frequently updated desk reference.
What's New in CustomRX
1.00
February 22, 2023
User reviews
Developer apps
FAQ
How do I get started with CustomRX?
Download the app, apply for an account, and a representative will approve your access after a review period. This ensures all users are qualified healthcare professionals.
Is CustomRX compliant with privacy regulations?
Yes, CustomRX meets all HIPAA and PIPEDA compliance regulations, ensuring the security and privacy of patient information.
Can CustomRX help me communicate with patients?
Yes, CustomRX includes a patient communication feature that alerts your patients when their prescriptions are ready for pickup.
How often is the CustomRX desk reference updated?
The desk reference within CustomRX is frequently updated, providing you with the latest information on custom compounds.
What is the age rating for CustomRX?
CustomRX is rated for users aged 17 and older, reflecting its professional audience and the nature of medical information.
What devices is CustomRX available on?
Based on the provided data, CustomRX is a mobile application. Specific device compatibility (iOS/Android) is not detailed but it is designed for on-demand access.
What is the update frequency for CustomRX?
CustomRX was last updated on February 22, 2023, with version 1.00. Further update frequency details are not provided.
What is the user sentiment for CustomRX?
Currently, CustomRX has a rating of 1.0 stars from 1 rating. This indicates a very limited user base and potentially negative initial feedback.


